- $24.08m
- $6.12m
- $150.36m
- 77
- 86
- 30
- 70
Annual income statement for Clps, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
C2019 June 30th | C2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 64.9 | 89.4 | 126 | 152 | 150 |
| Cost of Revenue | |||||
| Gross Profit | 23.8 | 31.1 | 40.2 | 41 | 34.5 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 68 | 86.2 | 118 | 145 | 150 |
| Operating Profit | -3.09 | 3.21 | 8.38 | 7.41 | 0.076 |
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -3.1 | 3.71 | 8.32 | 7.68 | 0.77 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -3.29 | 2.87 | 7.06 | 4.64 | 0.095 |
| Minority Interest | |||||
| Equity in Affiliates | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -3.27 | 2.94 | 6.82 | 4.46 | 0.193 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -3.27 | 2.94 | 6.82 | 4.46 | 0.193 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.236 | 0.2 | 0.388 | 0.212 | 0.075 |
| Special Dividends per Share |